Author: Qadir, Nida; Chang, Steven Y.
Title: Pharmacologic Treatments for Acute Respiratory Distress Syndrome Cord-id: h08areqx Document date: 2021_9_18
ID: h08areqx
Snippet: Acute respiratory distress syndrome is a heterogenous syndrome with many etiologies for which there are no definitive pharmacologic treatments, despite decades of research. We explore some adjunctive pharmacologic therapies, including neuromuscular blockade, corticosteroids, and inhaled pulmonary vasodilators. Additionally, we explore some investigative therapies, including Vitamin C, beta-agonists, statins, mesenchymal stromal cells, and granulocyte–macrophage colony stimulating factor. We do
Document: Acute respiratory distress syndrome is a heterogenous syndrome with many etiologies for which there are no definitive pharmacologic treatments, despite decades of research. We explore some adjunctive pharmacologic therapies, including neuromuscular blockade, corticosteroids, and inhaled pulmonary vasodilators. Additionally, we explore some investigative therapies, including Vitamin C, beta-agonists, statins, mesenchymal stromal cells, and granulocyte–macrophage colony stimulating factor. We do discuss the potential role of steroids in acute respiratory distress syndrome with severe acute respiratory syndrome coronavirus 2 as a trigger. The standard of care, however, remains supportive care.
Search related documents:
Co phrase search for related documents- action mechanism and long term outcome: 1
- action mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- action mechanism and lung injury inflammation: 1
- action mechanism and lung injury model: 1, 2, 3
- action mechanism and lung vascular permeability: 1
Co phrase search for related documents, hyperlinks ordered by date